✦ LIBER ✦

A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors

✍ Scribed by Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose escalation study of MK-0457

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB

Phase I dose-escalation study of AZD7762

✍ Sausville, Edward; LoRusso, Patricia; Carducci, Michael; Carter, Judith; Quinn, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 560 KB

A phase I dose escalation study of epide

✍ Karp, D.D; Ferrante, K.J; Tensfeldt, T.G; Thurer, R.L; LoCicero, J; Huberman, M. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Sunitinib in combination with docetaxel

✍ Francisco Robert; Alan Sandler; Joan H. Schiller; Glenn Liu; Karen Harper; Lev V 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

Phase I dose-escalation study of the HSP

✍ Toshihiko Doi,Yusuke Onozawa,Nozomu Fuse… 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 733 KB

A first-in-human dose-escalation study o

✍ Pant, Shubham; Burris, Howard A.; Moore, Kathleen; Bendell, Johanna C.; Kurkjian 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 176 KB